While microbial products do not play any role in tumor–immune interactions, a variety of molecules have been described that can mimic the effects of LPS by binding either to TLR4 or its coreceptor MD-2 and thereby promoting the activation of monocytes and macrophages with a pro-inflammatory phenotype [42]. The gene discussed is LY96; the disease is neoplasm.